510(k) Report

510(k) · Cleared

Cleared

Eptfe Slftm Spiral Vascular Graft

K083169510(k) TraditionalCleared Mar 30, 2009154-day reviewClass II21 CFR 870.3450

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tayside Flow Technologies Limited · DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Cleared on Mar 30, 2009 as substantially equivalent to K051312 (Veryan Medical Limited, 2005) and 3 other predicates after a 154-day review. Its family tree reaches back 2 generations to 1998. 4 later devices descend from it.

Decided
Mar 30, 2009
Review
154 days
Class
Class II
Product code
DSY
Recalls
None
Predicates
4

Its longest line of descent runs back 2 generations to K983861 (1998). 5 ancestors in all. 4 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 2 other ancestors1999: 1 other ancestor2014: 1 descendant cleared2015: 1 descendant cleared2010: 1 descendant cleared2025: 1 descendant clearedK983861 · Distaflo Bypass Graft · Impra, Inc. · 1998 · recalledK050049 · Dynaflo Bypass Graft · Bard Peripheral Vascular, Inc. · 20051995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 1 other ancestor 1 generation forward: 3 descendants2 generations forward: 1 descendant K050049 · Dynaflo Bypass Graft · Bard Peripheral Vascular, Inc. · 2005K983861 · Distaflo Bypass Graft · Impra, Inc. · 1998 · recalled0
  1. Root · 2 generations backK983861 Distaflo Bypass GraftImpra, Inc. · 1998 · Recalled
  2. 1 generation backK050049 Dynaflo Bypass GraftBard Peripheral Vascular, Inc. · 2005
  3. This deviceK083169 Eptfe Slftm Spiral Vascular GraftTayside Flow Technologies Limited · 2009
  4. Descendant · cites it directly · 1 of its ownK142062 Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd. · 2014
  5. Descendant · cites it directly · 1 of its ownK094044 Spiral Laminar Flow Vascular Arteriovenous GraftTayside Flow Technologies Limited · 2010
  6. Descendant · 2 generations on · 0 of its ownK252277 Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies Limited · 2025
  7. Descendant · cites it directly · 0 of its ownK150389 Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd. · 2015

Most influential descendants

Showing 4 of 4 · See all
  • K142062Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd. · 2014 · cites it directly1descendant
  • K094044Spiral Laminar Flow Vascular Arteriovenous GraftTayside Flow Technologies Limited · 2010 · cites it directly1descendant
  • K252277Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies Limited · 2025 · 2 generations on0descendants
  • K150389Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd. · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K983861Distaflo Bypass GraftImpra, Inc.19982
−1K050049Dynaflo Bypass GraftBard Peripheral Vascular, Inc.2005—
0 (this device)K083169Eptfe Slftm Spiral Vascular GraftTayside Flow Technologies Limited2009—
+1K142062Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd.2014—
+1K094044Spiral Laminar Flow Vascular Arteriovenous GraftTayside Flow Technologies Limited2010—
+2K252277Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies Limited2025—
+1K150389Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200520

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201410
201510
202510
FIG. 1 — Lineage of K083169, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSY device

  1. #1 K252445 Fusion Bioline Vascular Graftscore 12.4 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051312Swirlgraft Bypass and Vascular Access Grafts
Summary page 2
…for implantation. Summary of Substantial Equivalence: The ePTFE SLF TM Spiral Vascular Grafts are substantially equivalent to Veryan Medical Limited SwirlGraft Graft (K051312), Bard IMPRA DistaFlo® Bypass Graft (K983861), DynaFo TM Bypass Graft (K050049) and Vascutek PTFE Supported ePTFE Vascular Prosth…
Veryan Medical Limited2005—
*K983861Distaflo Bypass Graft
Summary page 2
…uivalence: The ePTFE SLF TM Spiral Vascular Grafts are substantially equivalent to Veryan Medical Limited SwirlGraft Graft (K051312), Bard IMPRA DistaFlo® Bypass Graft (K983861), DynaFo TM Bypass Graft (K050049) and Vascutek PTFE Supported ePTFE Vascular Prostheses (K043552) Device Description: The devi…
Impra, Inc.19982
*K050049Dynaflo Bypass Graft
Summary page 2
…l Vascular Grafts are substantially equivalent to Veryan Medical Limited SwirlGraft Graft (K051312), Bard IMPRA DistaFlo® Bypass Graft (K983861), DynaFo TM Bypass Graft (K050049) and Vascutek PTFE Supported ePTFE Vascular Prostheses (K043552) Device Description: The device is a vascular graft which has a…
Bard Peripheral Vascular, Inc.2005—
*K043552Vascutek Ptfe Supported Eptfe Vascular Prostheses
Summary page 2
…Limited SwirlGraft Graft (K051312), Bard IMPRA DistaFlo® Bypass Graft (K983861), DynaFo TM Bypass Graft (K050049) and Vascutek PTFE Supported ePTFE Vascular Prostheses (K043552) Device Description: The device is a vascular graft which has a specially designed section intended to induce spiral laminar fl…
Vascutek, Ltd.2005—

Also cleared against K051312: 1 other device →

What descends from it? (4)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K142062Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd.20141
K094044Spiral Laminar Flow Vascular Arteriovenous GraftTayside Flow Technologies Limited20101
K150389Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd.20150

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 3 companies; a new generation was cleared every 6.2 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K142062 (Vascular Flow Technologies, Ltd., 2014) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K051312.

How does its category compare?

All DSY devices

DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · DSY

2in 2025

2007: 12008: 12009: 52010: 42011: 12012: 42013: 52014: 22015: 12016: 12017: 32018: 12019: 12020: 12021: 22022: 22023: 22024: 52025: 22026 (partial year): 1
2007high 5 (2009) · low 1 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSY

160in 2024

2009: 73 days median2010: 55 days median2012: 30 days median2013: 69 days median2017: 269 days median2024: 160 days median
2007high 269 (2017) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSY

1in 2025

2009: 22010: 52013: 12016: 22025: 12026 (partial year): 1
2007high 5 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSY

151in 2025

2007: 1202008: 1642009: 1932010: 1872011: 1652012: 1772013: 2072014: 3522015: 4602016: 2172017: 1932018: 2002019: 2322020: 1692021: 1682022: 1552023: 1492024: 1532025: 151
2007high 460 (2015) · low 120 (2007)2025

MAUDE reports naming product code DSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—0120
20081—0164
20095732193
20104555187
20111—0165
20124300177
20135691207
20142—0352
20151—0460
20161—2217
201732690193
20181—0200
20191—0232
20201—0169
20212—0168
20222—0155
20232—0149
202451600153
20252—1151
20261—1—

What is it indicated for?

The ePTFE SLF™ Spiral Vascular Graft is indicated for ruse as a vascular prosthesis. It is intended for use in the bypass of reconstruction of occluded or diseased peripheral arterial blood vessels above or below the knee. Graft configurations are intended for use as arterial conduits for bypass, or reconstruction of peripheral arterial blood vessels.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K083169: Eptfe Slftm Spiral Vascular Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K083169

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026